$31.22
0.591.94%
At close: Sep 16, 5:00 PM EST
$30.00
-0.62-2.04%
Pre-Market: 6:00 AM EST
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Calculators
Compare Best Stocks
Roundhill GLP-1 & Weight Loss ETF (OZEM) Stock Price, Quote, News & History
OZEMNASDAQ
Roundhill GLP-1 & Weight Loss ETF (OZEM) Stock Price, Quote, News & History | Benzinga
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
57.60M
Fund Score
Loading...
Key Statistics
Open
-
High
-
52 Wk High
$37.15
AUM
57.60M
Dividend
$0.41
Ex-Div Date
Dec 30, 2025
Volume
-
Market Cap
$277.26B
Mgmt Fee
0.59%
P/E Ratio
36.69
Prev. Close
$30.62
Low
-
52 Wk Low
$26.17
Shares Out
1.87M
Yield
1.31%
Div. Freq
-
Avg. Volume Daily
15.95K
Beta
0.42
Avg. Expense Ratio
0.59%
P/B Ratio
4.69
Recent Roundhill GLP 1 And Weight Loss ETF News
FAQ
Q
How do I buy Roundhill GLP-1 & Weight Loss ETF (OZEM) stock?
A
You can purchase shares of Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) through any online brokerage.
Q
Who are Roundhill GLP-1 & Weight Loss ETF (OZEM) competitors?
A
There are no as such competitors for Roundhill GLP-1 & Weight Loss ETF.
Q
What is the forecast, or price target, for Roundhill GLP-1 & Weight Loss ETF (OZEM) stock?
A
There is no analysis for Roundhill GLP-1 & Weight Loss ETF to provide a consensus price target.
Q
What is the current price for Roundhill GLP-1 & Weight Loss ETF (OZEM)?
A
The stock price for Roundhill GLP-1 & Weight Loss ETF (NASDAQ: OZEM) is $30 last updated September 16, 2026 at 7:14 PM EDT.
Q
Does Roundhill GLP-1 & Weight Loss ETF (OZEM) pay a dividend?
A
There are no upcoming dividends for Roundhill GLP-1 & Weight Loss ETF.
Q
When is Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) reporting earnings?
A
Roundhill GLP-1 & Weight Loss ETF does not have any upcoming earnings scheduled.
Q
Is Roundhill GLP-1 & Weight Loss ETF (OZEM) going to split?
A
There is no upcoming split for Roundhill GLP-1 & Weight Loss ETF.
Key Statistics
Open
-
High
-
52 Wk High
$37.15
AUM
57.60M
Dividend
$0.41
Ex-Div Date
Dec 30, 2025
Volume
-
Market Cap
$277.26B
Mgmt Fee
0.59%
P/E Ratio
36.69
Prev. Close
$30.62
Low
-
52 Wk Low
$26.17
Shares Out
1.87M
Yield
1.31%
Div. Freq
-
Avg. Volume Daily
15.95K
Beta
0.42
Avg. Expense Ratio
0.59%
P/B Ratio
4.69
About
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Large Cap Blend |
| Fund Inception | May 21, 2024 |
| Managers | Todd Alberico Drew Walsh Tim Maloney Gabriel Tan Andrew Serowik Dave Mazza Will Hershey Brian Cooper |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
Investment Policy
The Fund is an actively managed exchange-traded fund (ETF) that pursues its investment objective by seeking to provide exposure to companies involved in the development of pharmaceutical drugs and/or supplements that can be utilized to help individuals lose weight, maintain an ideal weight, and/or maintain body composition during weight loss (GLP-1 & Weight Loss Drugs).
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved